申请人:Massachusetts College of Pharmacy
公开号:US20020115655A1
公开(公告)日:2002-08-22
The invention involves the identification of a family of compounds which block calcium channels. The compounds can be formulated in pharmaceutical carriers and administered to subjects. The compounds are useful for treating disorders associated with calcium channel activity, such as, cardiovascular diseases, for example hypertension, congestive heart failure, arrhythmia and angina.
这项发明涉及识别一类阻断钙通道的化合物家族。这些化合物可以制成药物载体并用于治疗相关于钙通道活性的疾病,例如心血管疾病,如高血压、心力衰竭、心律失常和心绞痛。